iPerian Snags Google Venture Funding

The quickly expanding biotech, iPerian, is forging ahead with their plans to use patient-derived iPS cells for drug discovery efforts. Google Venture, a like-minded organization driven by innovative technology, is backing iPerian with $22 million dollars in Series B funding.

Click here to read more.

Share this: